Hisamitsu Pharmaceutical Co
4530.T
Filed as Hisamitsu Pharmaceutical Co.,Inc. (2022-07–2025-10)
Financials · Standalone
| Fiscal year ended | 2025-02 | 2024-02 | 2023-02 | 2022-02 | 2021-02 | 2020-02 |
|---|---|---|---|---|---|---|
| Revenue | ¥102.6bn | ¥96.6bn | ¥93.0bn | ¥90.6bn | ¥86.7bn | ¥109.8bn |
| Operating income | ¥13.7bn | ¥10.7bn | ¥10.8bn | ¥8.6bn | — | — |
| Ordinary income | ¥16.5bn | ¥14.2bn | ¥14.1bn | ¥10.6bn | ¥10.4bn | ¥21.5bn |
| Total assets | ¥249.2bn | ¥256.0bn | ¥254.0bn | ¥254.3bn | ¥264.1bn | ¥266.1bn |
| Net assets / equity | ¥208.6bn | ¥212.8bn | ¥214.5bn | ¥222.4bn | ¥231.2bn | ¥225.6bn |
| EPS (basic) | ¥222.2 | ¥128.08 | ¥131.21 | ¥88.25 | ¥102.07 | ¥183.45 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 12
| Period | Form | Figures |
|---|---|---|
| 2025-03-01 → 2025-08-31 | Half-year | 70 figures · EDINET |
| 2024-03-01 → 2025-02-28 | Annual | 206 figures · EDINET |
| 2024-03-01 → 2024-08-31 | Half-year | 70 figures · EDINET |
| 2024-03-01 → 2024-05-31 | Quarterly Q1 | 46 figures · EDINET |
| 2023-03-01 → 2024-02-29 | Annual | 206 figures · EDINET |
| 2023-03-01 → 2023-11-30 | Quarterly Q3 | 48 figures · EDINET |
| 2023-03-01 → 2023-08-31 | Quarterly Q2 | 72 figures · EDINET |
| 2023-03-01 → 2023-05-31 | Quarterly Q1 | 46 figures · EDINET |
| 2022-03-01 → 2023-02-28 | Annual | 206 figures · EDINET |
| 2022-03-01 → 2022-11-30 | Quarterly Q3 | 48 figures · EDINET |
| 2022-03-01 → 2022-08-31 | Quarterly Q2 | 72 figures · EDINET |
| 2022-03-01 → 2022-05-31 | Quarterly Q1 | 46 figures · EDINET |
22 more reports are still being processed.